Antonio R. De Arellano
Zurich, ZH, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Economic Evaluation of Patiromer in Patients with Concomitant Heart Failure and Chronic Kidney Disease in Italy.
Journal: PharmacoEconomics - open
Published: April 13, 2025
Budget Impact of Preoperative Anemia Management, the First Pillar of Patient Blood Management, on the Romanian Healthcare System.
Journal: Clinical drug investigation
Published: January 16, 2025
A projected cost-utility analysis of avacopan for the treatment of antineutrophil cytoplasmic antibody-associated vasculitis in Spain.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: December 21, 2023
Hyperkalemia in chronic kidney disease patients with and without heart failure: an Italian economic modelling study.
Journal: Cost effectiveness and resource allocation : C/E
Published: July 14, 2023
Epidemiology and risk factors for hyperkalaemia in heart failure.
Journal: ESC heart failure
Published: June 13, 2023
Impact of ferric carboxymaltose for iron deficiency at discharge after heart failure hospitalization: a European multinational economic evaluation.
Journal: European journal of heart failure
Published: October 27, 2022
A cost-effectiveness analysis of patiromer in the UK: evaluation of hyperkalaemia treatment and lifelong RAASi maintenance in chronic kidney disease patients with and without heart failure.
Journal: BMC nephrology
Published: October 20, 2022
The Cost Effectiveness of Patiromer for the Treatment of Hyperkalaemia in Patients with Chronic Kidney Disease with and without Heart Failure in Ireland.
Journal: PharmacoEconomics - open
Published: July 10, 2022
Patiromer utilization in patients with advanced chronic kidney disease under nephrology care in Germany.
Journal: Clinical kidney journal
Published: June 01, 2022
Cost-effectiveness analysis of ferric carboxymaltose versus iron sucrose for the treatment of iron deficiency anemia in patients with inflammatory bowel disease in Spain.
Journal: Therapeutic advances in gastroenterology
Published: August 06, 2021
Evaluation of the Cost-Effectiveness of Iron Formulations for the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease in the UK.
Journal: ClinicoEconomics and outcomes research : CEOR
Published: March 19, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026